Robert Penny

71.0k total citations
13 papers, 704 citations indexed

About

Robert Penny is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Robert Penny has authored 13 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Robert Penny's work include Cancer Genomics and Diagnostics (5 papers), Peripheral Neuropathies and Disorders (2 papers) and Molecular Biology Techniques and Applications (2 papers). Robert Penny is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Peripheral Neuropathies and Disorders (2 papers) and Molecular Biology Techniques and Applications (2 papers). Robert Penny collaborates with scholars based in United States and Australia. Robert Penny's co-authors include J. G. McLeod, Daniel D. Von Hoff, Mitesh J. Borad, Michael Bittner, Geraldine S. Pinkus, John Blaustein, Janina A. Longtine, David Mallery, Susan B. Brown and Donald Richards and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Robert Penny

13 papers receiving 679 citations

Peers

Robert Penny
H. Roché France
KyungMann Kim United States
Todd Riehl United States
Edna Chow‐Maneval United States
Brendan Rooney United Kingdom
M E van der Burg Netherlands
H. Roché France
Robert Penny
Citations per year, relative to Robert Penny Robert Penny (= 1×) peers H. Roché

Countries citing papers authored by Robert Penny

Since Specialization
Citations

This map shows the geographic impact of Robert Penny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Penny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Penny more than expected).

Fields of papers citing papers by Robert Penny

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Penny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Penny. The network helps show where Robert Penny may publish in the future.

Co-authorship network of co-authors of Robert Penny

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Penny. A scholar is included among the top collaborators of Robert Penny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Penny. Robert Penny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Morris, Scott, Esma S. Gel, Joseph Paulauskis, et al.. (2013). Two Algorithms for Biospecimen Comparison and Differentiation using SNP Genotypes. Pharmacogenomics. 14(4). 379–390. 2 indexed citations
2.
Tomlins, Scott A., Daniel Robinson, Robert Penny, & Jay L. Hess. (2012). Twenty-First Century Pathology Sign-Out. Clinics in Laboratory Medicine. 32(4). 639–650. 2 indexed citations
3.
Weiss, Glen J., et al.. (2010). Molecular characterization of interdigitating dendritic cell sarcoma. Rare Tumors. 2(3). 144–145. 10 indexed citations
4.
Hoff, Daniel D. Von, Joseph J. Stephenson, Peter J. Rosen, et al.. (2010). Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers. Journal of Clinical Oncology. 28(33). 4877–4883. 434 indexed citations
5.
Borad, Mitesh J., Robert Penny, Michael Bittner, et al.. (2006). Molecular profiling using immunohistochemistry (IHC) and DNA microarray (DMA) as a tool to determine potential therapeutic targets in patients who have progressed on multiple prior therapies. Clinical Cancer Research. 12. 4 indexed citations
6.
Hoff, Daniel D. Von, Robert Penny, S Shack, et al.. (2006). Frequency of potential therapeutic targets identified by immunohistochemistry (IHC) and DNA microarray (DMA) in tumors from patients who have progressed on multiple therapeutic agents. Journal of Clinical Oncology. 24(18_suppl). 3071–3071. 15 indexed citations
7.
Henry, Helen L., et al.. (1992). The cellular and molecular regulation of 1,25(OH)2D3 production. The Journal of Steroid Biochemistry and Molecular Biology. 41(3-8). 401–407. 19 indexed citations
8.
Penny, Robert, Janina A. Longtine, Geraldine S. Pinkus, & John Blaustein. (1991). Ki-1–positive large cell lymphomas, a heterogenous group of neoplasms. Morphologic, immunophenotypic, genotypic, and clinical features of 24 cases. Cancer. 68(2). 362–373. 97 indexed citations
9.
Penny, Robert. (1982). Pediatrics-epitomes of progress: the effect of des on male offspring.. PubMed. 136(4). 329–30. 2 indexed citations
10.
Davis, John R. & Robert Penny. (1981). Improved Fluorescence Method for Identifying Sex Chromatin in Formalin-fixed Tissue. American Journal of Clinical Pathology. 75(5). 731–733. 6 indexed citations
11.
Penny, Robert. (1978). The Monoclonal Gammopathies: Multiple Myeloma and Related Plasma-Cell Disorders. Pathology. 10(1). 91–91. 8 indexed citations
12.
Davies, William A., et al.. (1975). Phagocytosis and the gamma globulin monolayer: analysis by particle electrophoresis.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 18(2). 136–48. 1 indexed citations
13.
McLeod, J. G. & Robert Penny. (1969). Vincristine neuropathy: an electrophysiological and histological study.. Journal of Neurology Neurosurgery & Psychiatry. 32(4). 297–304. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026